duoresp spiromax
teva pharma b.v. - budesonide, formoterol fumarate dihydrate - pulmonary disease, chronic obstructive; asthma - léky na obstrukční onemocnění dýchacích cest, - asthma duoresp spiromax is indicated in adults and adolescents (12 years and older) for the regular treatment of asthma, where use of a combination (inhaled corticosteroid and long-acting β₂ adrenoceptor agonist) is appropriate:in patients not adequately controlled with inhaled corticosteroids and “as needed” inhaled short-acting β₂ adrenoceptor agonists. orin patients already adequately controlled on both inhaled corticosteroids and long-acting β₂ adrenoceptor agonists. copdduoresp spiromax is indicated in adults, aged 18 years and older for the symptomatic treatment of patients with copd with forced expiratory volume in 1 second (fev₁).
zelboraf
roche registration gmbh - vemurafenib - melanom - antineoplastická činidla - vemurafenib je indikován v monoterapii k léčbě dospělých pacientů s pozitivním neresekovatelným nebo metastatickým melanomem pozitivním na mutaci braf-v600.
spectrila
medac gesellschaft fuer klinische spezialpraeparate mbh - asparagináza - prekurzorová buněčná lymfoblastická leukémie-lymfom - antineoplastická činidla - spectrila je indikován jako složka cytostatické kombinované terapie k léčbě akutní lymfoblastické leukémie (all) u pediatrických pacientů od narození do 18 let a dospělé.
ogluo
tetris pharma b.v - glukagon - diabetes mellitus - pankreatické hormony, hormony glycogenolytic - ogluo is indicated for the treatment of severe hypoglycaemia in adults, adolescents, and children aged 2 years and over with diabetes mellitus.
response®
adama - ve vodě dispergovatelné granule - pyroxsulam - herbicidy
locametz
novartis europharm limited - gozetotide - radionuklidové zobrazování - diagnostické radiofarmaka - tento léčivý přípravek je určen pouze pro diagnostické účely. locametz, after radiolabelling with gallium 68, is indicated for the detection of prostate specific membrane antigen (psma) positive lesions with positron emission tomography (pet) in adults with prostate cancer (pca) in the following clinical settings:primary staging of patients with high risk pca prior to primary curative therapy,suspected pca recurrence in patients with increasing levels of serum prostate specific antigen (psa) after primary curative therapy,identification of patients with psma positive progressive metastatic castration resistant prostate cancer (mcrpc) for whom psma targeted therapy is indicated (see section 4.
arufil 20mg/ml oční kapky, roztok
bausch + lomb ireland limited, dublin array - 18178 povidon k 30 - oční kapky, roztok - 20mg/ml - umĚlÉ slzy a jinÉ indiferentnÍ pŘÍpravky
atominex 10mg tvrdá tobolka
zentiva, k.s., praha array - 17338 atomoxetin-hydrochlorid - tvrdá tobolka - 10mg - atomoxetin
atominex 100mg tvrdá tobolka
zentiva, k.s., praha array - 17338 atomoxetin-hydrochlorid - tvrdá tobolka - 100mg - atomoxetin
atominex 18mg tvrdá tobolka
zentiva, k.s., praha array - 17338 atomoxetin-hydrochlorid - tvrdá tobolka - 18mg - atomoxetin